Research News
View articles by month and year
-
Women Taking Statins Have Fewer Heart Problems During Anthracycline Chemotherapy
A study found that women who were taking a statin during and after being treated for breast cancer with anthracycline chemotherapy had fewer heart problems than women who weren’t taking a statin.
-
Use of Anthracyclines to Treat Breast Cancer Has Gone Down
A study has found that after 2005, there was a large increase in taxane chemotherapy and a decrease in anthracycline chemotherapy to treat breast cancer in the United States.
-
Chemo During Pregnancy Appears Safe for Mother and Child
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Research Suggests How Metastatic Cancer Becomes Resistant to Chemotherapy
A very early study on cancer cells in petri dishes in the lab has found that a type of cell called a fibroblast also is damaged by chemotherapy. Damaged fibroblasts make a protein called WNT16B that may help metastatic cancer cells become resistant to chemotherapy and grow.
-
Halavan May Help Treat Metastatic Disease
Women diagnosed with metastatic breast cancer that didn't respond to other treatments who got Halavan lived 2 months longer than women who got supportive care or a standard metastatic cancer treatment.
-
Xeloda Doesn’t Seem to Reduce Recurrence Risk
A new study shows that the risk of recurrence is the same whether or not Xeloda was added to a standard adjuvant chemotherapy regimen for early-stage breast cancer with a high risk of recurrence.
-
Chemo During Pregnancy Doesn’t Harm Baby
New research supports other studies that suggest that chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Taxotere Better Than Fluorouracil in Chemo Regimen After Surgery for Early-Stage Disease
Chemotherapy that included Taxotere offered slightly better results than a regimen that included 5-FU for women diagnosed with early-stage breast cancer that hadn't spread to the lymph nodes, but Taxotere was more likely to cause serious side effects.
-
Halaven Approved by FDA to Treat Metastatic Breast Cancer
The FDA has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemotherapy medicines.
-
New Technique May Find Heart Damage Earlier
Research suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional measurement tests.
